11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor Development by Lentiviral Screening Based on Computational Modeling

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Pharmacology

• Publication date

  2018-08-10

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1159/000491397PMID 30099452
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Beneficial Effects of Corn Silk on Metabolic Syndrome.

  2017cited by this paper
• Establishing the first institutional animal care and use committee in Egypt

  2016cited by this paper
• Emerging Role of Corticosteroid-Binding Globulin in Glucocorticoid-Driven Metabolic Disorders

  2016cited by this paper
• Soliciting Stakeholder Input for a Revision of Biosafety in Microbiological and Biomedical Laboratories (BMBL): Proceedings of a Workshop

  2016cited by this paper
• The 11β-hydroxysteroid dehydrogenase type 1 inhibitor protects against the insulin resistance and hepatic steatosis in db/db mice.

  2016cited by this paper
• Nonylphenol-induced hyperadrenalism can be reversed/alleviated by inhibiting of 11-β hydroxysteroid dehydrogenase type 1.

  2016cited by this paper
• Glucocorticoid antagonism limits adiposity rebound and glucose intolerance in young male rats following the cessation of daily exercise and caloric restriction.

  2016cited by this paper
• Obesity and Type 2 Diabetes in Children: Epidemiology and Treatment

  2014cited by this paper
• Synthesis of novel curcumin analogues for inhibition of 11β-hydroxysteroid dehydrogenase type 1 with anti-diabetic properties.

  2014cited by this paper
• Synthesis of 2-{2-[(α/β-naphthalen-1-ylsulfonyl)amino]-1,3-thiazol-4-yl} acetamides with 11β-hydroxysteroid dehydrogenase inhibition and in combo antidiabetic activities.

  2014cited by this paper
• Hypothalamic-pituitary-adrenal (HPA) axis and aging.

  2014cited by this paper
• Discovery of ZAP70 inhibitors by high-throughput docking into a conformation of its kinase domain generated by molecular dynamics.

  2013cited by this paper
• BVT.2733, a Selective 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor, Attenuates Obesity and Inflammation in Diet-Induced Obese Mice

  2012cited by this paper
• Structure-based and property-compliant library design of 11β-HSD1 adamantyl amide inhibitors.

  2011cited by this paper
• Adipose tissue-targeted 11β-hydroxysteroid dehydrogenase type 1 inhibitor protects against diet-induced obesity.

  2011cited by this paper
• Cushing's syndrome, glucocorticoids and the kidney.

  2010cited by this paper
• AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility

  2009cited by this paper
• Demonstration of Proof of Mechanism and Pharmacokinetics and Pharmacodynamic Relationship with 4′-Cyano-biphenyl-4-sulfonic Acid (6-Amino-pyridin-2-yl)-amide (PF-915275), an Inhibitor of 11β-Hydroxysteroid Dehydrogenase Type 1, in Cynomolgus Monkeys

  2008cited by this paper
• The discovery of 2-anilinothiazolones as 11beta-HSD1 inhibitors.

  2007cited by this paper
• Faculty Opinions recommendation of 11beta-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice.

  2005cited by this paper
• 11beta-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice.

  2005cited by this paper
• The Functional Consequences of 11β-Hydroxysteroid Dehydrogenase Expression in Adipose Tissue

  2002cited by this paper
• Selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice

  2002cited by this paper
• 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors

  2001cited by this paper
• 11 b-Hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress

  1997cited by this paper
• NAD(+)-dependent isoform of 11 beta-hydroxysteroid dehydrogenase. Cloning and characterization of cDNA from sheep kidney.

  1994cited by this paper
• The human gene for 11 beta-hydroxysteroid dehydrogenase. Structure, tissue distribution, and chromosomal localization.

  1991cited by this paper

• Development of a coupled time-domain model for complexly moored multi-body system with application in catamaran float-over deck installation

  2025cites this paper
• 11β-HSD1 inhibitor alleviates lipid metabolism disorder by activating the AMPK signaling pathway

  2025cites this paper
• Bone Marrow Mesenchymal Stem Cell-Derived Nanovesicles Containing H8 Improve Hepatic Glucose and Lipid Metabolism and Exert Ameliorative Effects in Type 2 Diabetes

  2024cites this paper
• 11β-HSD1 Inhibitor Alleviates Non-Alcoholic Fatty Liver Disease by Activating the AMPK/SIRT1 Signaling Pathway

  2022cites this paper
• Naringenin Attenuates Non-Alcoholic Fatty Liver Disease by Enhancing Energy Expenditure and Regulating Autophagy via AMPK

  2021cites this paper
• Celastrol attenuates high‐fructose diet‐induced inflammation and insulin resistance via inhibition of 11β‐hydroxysteroid dehydrogenase type 1 activity in rat adipose tissues

  2021cites this paper